Lamoste, Roscia .
HRN: 25-22-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CEFUROXIME 500MG (TAB)
09/17/2024
09/24/2024
PO
500mg Tab
BID
UTI
Waiting Final Action